eyepoint
pharmaceuticals
announces
participation
upcoming
investor
conferences
watertown
globe
newswire
eyepoint
pharmaceuticals
nasdaq
eypt
pharmaceutical
company
committed
developing
commercializing
innovative
ophthalmic
products
today
announced
nancy
lurker
president
chief
executive
officer
present
two
upcoming
virtual
conferences
september
cantor
virtual
healthcare
conference
date
tuesday
september
time
pm
eastern
time
wainwright
annual
global
investment
conference
date
wednesday
september
time
pm
eastern
time
live
webcast
subsequent
archived
replay
presentations
may
accessed
via
investors
section
company
website
replay
available
days
event
eyepoint
pharmaceuticals
eyepoint
pharmaceuticals
pharmaceutical
company
committed
developing
commercializing
innovative
ophthalmic
products
indications
high
unmet
medical
need
help
improve
lives
patients
serious
eye
disorders
company
currently
two
commercial
products
first
approved
intraocular
product
treatment
postoperative
inflammation
treatment
chronic
uveitis
affecting
posterior
segment
eye
company
pipeline
leverages
proprietary
bioerodible
technology
extended
intraocular
drug
delivery
including
potential
therapy
initially
targeting
wet
macular
degeneration
eyepoint
pharmaceuticals
headquartered
watertown
massachusetts
offices
basking
ridge
new
jersey
learn
company
please
visit
connect
twitter
linkedin
contacts
investors
argot
partners
sam
martin
joe
rayne
eyepoint
